Albert David Ltd. — Investor Relations & Filings
Albert David Ltd. specializes in the manufacturing and marketing of pharmaceutical formulations, infusions, and herbal preparations. The company’s product portfolio encompasses a wide range of therapeutic segments, including anti-infectives, gastrointestinal agents, and ophthalmic solutions. A significant area of expertise lies in the production of large and small volume parenterals and specialized placenta extract-based treatments used for tissue regeneration and wound healing. The organization maintains advanced production facilities and focuses on research and development to support its diverse clinical offerings. Its operations serve a broad spectrum of healthcare needs across various global markets, emphasizing quality control and technical precision in its manufacturing processes.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| Certificate under SEBI (Depositories and Participants) Regulations, 2018 | 2026-04-07 | English | |
| Disclosure under SEBI Takeover Regulations | 2026-04-07 | English | |
| Trading Window | 2026-03-23 | English | |
| Copy of Newspaper Publication | 2026-03-13 | English | |
| Copy of Newspaper Publication | 2026-03-11 | English | |
| Cessation | 2026-03-10 | English |
Browse filings by year
11 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
13 filings
| |||||
| 42199383 | Certificate under SEBI (Depositories and Participants) Regulations, 2018 | 2026-04-07 | English | ||
| 42201053 | Disclosure under SEBI Takeover Regulations | 2026-04-07 | English | ||
| 42205449 | Trading Window | 2026-03-23 | English | ||
| 42196147 | Copy of Newspaper Publication | 2026-03-13 | English | ||
| 42172583 | Copy of Newspaper Publication | 2026-03-11 | English | ||
| 42177873 | Cessation | 2026-03-10 | English | ||
| 42188184 | Copy of Newspaper Publication | 2026-02-12 | English | ||
| 42210300 | Integrated Filing- Financial | 2026-02-11 | English | ||
| 42211303 | Outcome of Board Meeting | 2026-02-11 | English | ||
| 43879736 | Board Meeting — Board Meeting Intimation | 2026-02-02 | English | ||
| 43879757 | Board Meeting — Financial Results | 2026-02-02 | English | ||
| 42209826 | Change in Management | 2026-01-17 | English | ||
| 42233902 | Certificate under SEBI (Depositories and Participants) Regulations, 2018 | 2026-01-05 | English | ||
|
2025
2 filings
| |||||
| 42232770 | Trading Window | 2025-12-22 | English | ||
| 42233724 | Trading Window | 2025-12-22 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Ellen AB
Biotechnology company developing products for women's intim…
|
ELN | SE | Manufacturing |
|
ELUTIA INC.
Develops drug-eluting biomaterials for medical implants and…
|
ELUT | US | Manufacturing |
|
Emblem Corp.
Licensed producer and distributor of medically-focused cann…
|
— | CA | Manufacturing |
|
Emcure Pharmaceuticals Limited
Global pharmaceutical firm developing complex generics and …
|
EMCURE | IN | Manufacturing |
|
Emergent BioSolutions Inc.
Develops and delivers medical countermeasures for public he…
|
EBS | US | Manufacturing |
|
Emmessar Biotech & Nutrition Ltd.
Researches and manufactures biotech-based healthcare and nu…
|
524768 | IN | Manufacturing |
|
ENANTA PHARMACEUTICALS INC
Biotechnology company developing small molecule drugs for v…
|
ENTA | US | Manufacturing |
|
Enervit
Develops sports nutrition, functional foods, and wellness s…
|
ENV | IT | Manufacturing |
|
enGene Holdings Inc.
Clinical-stage biotech developing non-viral gene therapies …
|
ENGN | CA | Manufacturing |
|
Enliven Therapeutics, Inc.
Clinical-stage biopharma developing kinase inhibitors for p…
|
ELVN | US | Manufacturing |
Albert David Ltd. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/60428/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=60428 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=60428 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=60428 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 60428}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Albert David Ltd. (id: 60428)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.